Selected article for: "important risk factor and risk factor"
Author: Jianjian Wang; Yuyi Tang; Yanfang Ma; Qi Zhou; Weiguo Li; Muna Baskota; Yinmei Yang; Xingmei Wang; Qingyuan Li; Xufei Luo; Toshio Fukuoka; Hyeong Sik Ahn; Myeong Soo Lee; Zhengxiu Luo; Enmei Liu; Yaolong Chen
Title: Efficacy and Safety of Antibiotic Agents in Children with COVID-19: A Rapid Review
  • Document date: 2020_4_17
    • ID: jubwcobb_57
    Snippet: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10. 1101 researchers have emphasized the importance of toxic side effects and drug resistance to antibiotics (75) , and many studies have also analyzed the bacterial types and drug resistance of secondary bacterial infections in SARS patients. Secondary infections are considered as an important risk factor for mortality in SARS patients (76, 77) . This i.....
    Document: The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10. 1101 researchers have emphasized the importance of toxic side effects and drug resistance to antibiotics (75) , and many studies have also analyzed the bacterial types and drug resistance of secondary bacterial infections in SARS patients. Secondary infections are considered as an important risk factor for mortality in SARS patients (76, 77) . This is the first systematic review aiming to assess the application of antibiotic agents for children with COVID-19. This study summarizes the literature on the efficacy and safety of antibiotic agents in the treatment of patients with COVID-19, SARS, and MERS.

    Search related documents:
    Co phrase search for related documents
    • bacterial infection and drug resistance: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • bacterial infection and literature summarize: 1, 2
    • bacterial infection and risk factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bacterial infection and safety efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • bacterial infection and SARS patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • bacterial infection and secondary infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • bacterial infection and secondary SARS patient bacterial infection: 1
    • bacterial type and drug resistance: 1, 2
    • bacterial type and risk factor: 1
    • bacterial type and secondary infection: 1, 2, 3
    • drug resistance and literature summarize: 1, 2
    • drug resistance and risk factor: 1, 2, 3, 4, 5
    • drug resistance and safety efficacy: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • drug resistance and SARS patient: 1, 2, 3
    • drug resistance and secondary infection: 1, 2, 3
    • drug resistance and secondary SARS patient bacterial infection: 1
    • literature summarize and SARS patient: 1, 2
    • literature summarize and secondary infection: 1, 2, 3
    • literature summarize and study literature summarize: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14